CASR and colorectal carcinoma: Therefore, we investigated the impact of the wild-type CaSR and a dominant negative mutant CaSR (R185Q) on the tumorigenic potential of two well characterized-CRC cell lines: the more differentiated Caco2-15 and the highly tumorigenic HT29 [26,28,29].